Alopecia Clinical Trials

A listing of Alopecia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Phoenix Arizona 85018

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Arkansas

UPDATED

Jonesboro Arkansas 72401

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

California

UPDATED

Oceanside California 92056

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Santa Ana California 92701

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

Santa Monica California 90404

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Connecticut

UPDATED

Milford Connecticut 06460

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

New Haven Connecticut 06519

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

View More ▼

UPDATED

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Florida

UPDATED

DeLand Florida 32720

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Hialeah Florida 33012

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Jacksonville Florida 32207

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Miami Florida 33175

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

North Miami Florida 33161

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

View More ▼

UPDATED

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

Orlando Florida 32806

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Tampa Florida 33613

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Tampa Florida 33624

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

Tampa Florida 33609

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

Tampa Florida 33609

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Georgia

UPDATED

Atlanta Georgia 30342

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Newnan Georgia 30263

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Idaho

UPDATED

Boise Idaho 83642

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Illinois

UPDATED

Champaign Illinois 61820

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Indiana

UPDATED

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Kansas

UPDATED

Shawnee Mission Kansas 66218

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Massachusetts

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Montana

UPDATED

Billings Montana 59102

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

New York

UPDATED

New York New York 10029

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

UPDATED

Williamsville New York 14221

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

North Carolina

UPDATED

Cary North Carolina 27518

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Ohio

UPDATED

Cleveland Ohio 44122

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Columbus Ohio 43213

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Mayfield Heights Ohio 44124

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Tiffin Ohio 44883

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Oklahoma

UPDATED

Tulsa Oklahoma 74136-7028

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Pennsylvania

UPDATED

Bryn Mawr Pennsylvania 19010

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Hershey Pennsylvania 17033

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Philadelphia Pennsylvania 19104

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

South Carolina

UPDATED

Myrtle Beach South Carolina 29572

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

South Dakota

UPDATED

Rapid City South Dakota 57702

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Texas

UPDATED

Austin Texas 78749

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Utah

UPDATED

Salt Lake City Utah 84107

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Salt Lake City Utah 84124

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Virginia

UPDATED

Charlottesville Virginia 22911

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Norfolk Virginia 23502

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)